CAS: 529-44-2|Myricetin

Lub luag haujlwm tseem ceeb ntawm myricetin:
1) Antioxidant nyhuv: Myricetin yog ib qho muaj zog antioxidant, thiab oxidative kev nyuaj siab plays lub luag haujlwm tseem ceeb hauv ntau yam kab mob paj hlwb xws li ischemia thiab Alzheimer's disease. Myricetin txo qis kev tsim khoom thiab tshuaj lom ntawm -amylase los ntawm kev hloov pauv, thiab tuaj yeem siv los suav qhov kev loj hlob ntawm Alzheimer's disease.
2) Cov nyhuv los tiv thaiv qog: Myricetin yog ib qho tshuaj tiv thaiv zoo thiab kho mob rau cov kab mob carcinogenesis.
3) Txo cov neurotoxicity: Myricetin tuaj yeem tiv thaiv cov neurons los ntawm inhibiting neurotoxicity tshwm sim los ntawm glutamate los ntawm ntau txoj hauv kev, yog li tiv thaiv cov paj hlwb puas.
4) Kev cuam tshuam ntawm lymphocyte activation thiab proliferation: Myricetin tuaj yeem cuam tshuam qhov kev qhia ntawm CD69, qhov taw qhia thaum ntxov ntawm T hlwb, thiab inhibit lymphocyte proliferation teb.
5) Antagonism ntawm platelet activating factor (PAF): Myricetin inhibits PAF-induced WRP aggregation thiab 52HT tso tawm nyob rau hauv ib tug concentration-dependent yam nyob rau hauv vitro. Nyob rau tib lub sijhawm, nws tuaj yeem cuam tshuam qhov nce ntawm cov calcium dawb hauv platelets los ntawm PAF. Yog li, myricetin muaj ntau yam tshuaj kho mob plawv xws li tshuaj tiv thaiv thrombosis, tiv thaiv myocardial ischemia, thiab txhim kho microcirculation.
6) Cov nyhuv hypoglycemic: Myricetin muaj cov nyhuv hypoglycemic pom tseeb.

Specification of CAS: 529-44-2|Myricetin

Pob thiab kev thauj mus los ntawmCAS: 529-44-2|Myricetin

Pob: 1g, 10g, 25g 1kg 25kg

Kev thauj mus los: los ntawm courier / los ntawm huab cua / los ntawm hiav txwv